Impact of denosumab on bone mass in cancer patients

Impact of denosumab on bone mass in cancer patients

Ursa Brown-Glaberman, Alison T StopeckUniversity of Arizona Cancer Center, Tucson, AZ, USAAbstract: Cancer therapy-induced bone loss (CTIBL) is a form of secondary osteoporosis associated with systemic chemotherapy and hormonal ablation therapy. The monitoring and treatment of CTIBL is an important...

Full description

Bibliographic Details
Main Authors:	Brown-Glaberman U, Stopeck AT
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-07-01
Series:	Clinical Pharmacology : Advances and Applications
Online Access:	http://www.dovepress.com/impact-of-denosumab-on-bone-mass-in-cancer-patients-a13568

Similar Items

Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
by: Stopeck AT, et al.
Published: (2012-04-01)

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
by: Yee AJ, et al.
Published: (2012-09-01)

Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion
by: Guenther G. Steger, et al.
Published: (2011-09-01)

Management of bone metastases in refractory prostate cancer – role of denosumab
by: Paller CJ, et al.
Published: (2012-09-01)

Effect of risedronate on bone loss at discontinuation of denosumab
by: Michel Laroche, et al.
Published: (2020-12-01)

Efficiency of denosumab in giant cell tumor of the bone
by: N N Semenov
Published: (2013-06-01)

Impact of Monthly 120 mg Denosumab on Bone Metabolism in Bone-metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
by: Jimpei Miyakawa, et al.
Published: (2017-08-01)

Denosumab: a new option in the treatment of bone metastases from urological cancers
by: Yonese J, et al.
Published: (2012-09-01)

Effect of switching from bisphosphonates to denosumab on bone metabolism in aromatase inhibitor-treated breast cancer patients
by: Shizuku Masato, et al.
Published: (2017-09-01)

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
by: Alexander Upfill‐Brown, et al.
Published: (2019-10-01)

Treatment of medullary thyroid cancer with bone metastases with denosumab: A review and case illustration
by: Leslie S. Eldeiry, et al.
Published: (2020-09-01)

Denosumab for Breast Cancer with Bone Metastases-Induced Hypercalcemia Complicated with Acute Renal Failure
by: Chen-Yu Kuo, et al.
Published: (2015-06-01)

The current standing on the use of denosumab in giant cell tumour of the bone
by: Vivek Ajit Singh, et al.
Published: (2020-12-01)

Denosumab 10-year simulation of bone remodeling in human biopsies
by: Duncan C. Tourolle, et al.
Published: (2020-10-01)

Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls
by: Hengyuan Li, et al.
Published: (2020-10-01)

Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report
by: Shinya Otani, et al.
Published: (2019-09-01)

Aneurysmal bone cyst: results of an off label treatment with Denosumab
by: Hans Roland Dürr, et al.
Published: (2019-10-01)

Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
by: Ryan Carlisle Egbert, et al.
Published: (2017-01-01)

Giant-cell tumor of bone: treatment options and role of denosumab
by: Singh AS, et al.
Published: (2015-07-01)

Effect of denosumab on bone formation marker P1NP
by: Hitoshi Tanigawa, et al.
Published: (2017-09-01)

Clinical utility of denosumab for treatment of bone loss in men and women
by: Adler R, et al.
Published: (2011-05-01)

A recurrent giant cell tumor of bone treated with denosumab
by: Nicola Stadler, et al.
Published: (2015-02-01)

Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysis
by: Yuko Kanbayashi, et al.
Published: (2021-01-01)

Safety and efficacy of extended dosing intervals of denosumab in patients with solid cancers and bone metastases: a retrospective study
by: Aseala I. Abousaud, et al.
Published: (2020-12-01)

Treatment-Induced Bone Loss and Fractures in Cancer Patients Undergoing Hormone Ablation Therapy: Efficacy and Safety of Denosumab
by: Allan Lipton, et al.
Published: (2012-08-01)

Treatment-Induced Bone Loss and Fractures in Cancer Patients Undergoing Hormone Ablation Therapy: Efficacy and Safety of Denosumab
by: Allan Lipton, et al.
Published: (2012-01-01)

Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment
by: Nakamura Y, et al.
Published: (2018-03-01)

The Role Of Denosumab
by: Raditya Pria Utama, et al.
Published: (2019-07-01)

Comparison of Denosumab and Zoledronic acid as neoadjuvant therapy in patients with giant cell tumor of bone
by: Himanshu Kanwat, et al.
Published: (2021-07-01)

Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone
by: Jacob Engellau, et al.
Published: (2018-09-01)

Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients
by: Takako Suzuki, et al.
Published: (2017-08-01)

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
by: Tetsuya Kaneko, et al.
Published: (2019-10-01)

Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.
by: Kenta Mukaihara, et al.
Published: (2016-01-01)

Recurrent Aneurysmal Bone Cyst of the Distal Fibula Treated with Denosumab and Curettage
by: Philip B. Fontenot, et al.
Published: (2018-01-01)

Aggressive osteoblastoma with a secondary aneurysmal bone cyst treated with denosumab
by: Karlton Wong, et al.
Published: (2021-08-01)

Ten‐Year Simulation of the Effects of Denosumab on Bone Remodeling in Human Biopsies
by: Duncan C Tourolle, et al.
Published: (2021-06-01)

Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study
by: Hiroya Takami, et al.
Published: (2017-01-01)

The Role of Denosumab for Surgical Outcomes in Patients with Giant Cell Tumour of Bone: A Systematic Review
by: Abha Gupta, et al.
Published: (2021-03-01)

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients
by: Polyzois Makras, et al.
Published: (2021-12-01)